Departments of Surgery, Washington University School of Medicine, St Louis, MO, USA.
Crit Care Med. 2010 Mar;38(3):886-93. doi: 10.1097/CCM.0b013e3181c8fdb1.
Whereas most septic patients have an underlying comorbidity, most animal models of sepsis use mice that were healthy before the onset of infection. Malignancy is the most common comorbidity associated with sepsis. The purpose of this study was to determine whether mice with cancer have a different response to sepsis than healthy animals.
Prospective, randomized controlled study.
Animal laboratory in a university medical center.
C57Bl/6 mice.
Animals received a subcutaneous injection of either 250,000 cells of the transplantable pancreatic adenocarcinoma cell line Pan02 (cancer) or phosphate-buffered saline (healthy). Three weeks later, mice given Pan02 cells had reproducible, nonmetastatic tumors. Both groups of mice then underwent intratracheal injection of either Pseudomonas aeruginosa (septic) or 0.9% NaCl (sham). Animals were killed 24 hrs postoperatively or followed-up 7 days for survival.
Mice with cancer and healthy mice appeared similar when subjected to sham operation, although cancer animals had lower levels of T- and B-lymphocyte apoptosis. Septic mice with cancer had increased mortality compared to previously healthy septic mice subjected to the identical injury (52% vs. 28%; p = .04). This was associated with increased bacteremia but no difference in local pulmonary infection. Septic mice with cancer also had increased intestinal epithelial apoptosis. Although sepsis induced an increase in T- and B-lymphocyte apoptosis in all animals, septic mice with cancer had decreased T- and B-lymphocyte apoptosis compared to previously healthy septic mice. Serum and pulmonary cytokines, lung histology, complete blood counts, and intestinal proliferation were similar between septic mice with cancer and previously healthy septic mice.
When subjected to the same septic insult, mice with cancer have increased mortality compared to previously healthy animals. Decreased systemic bacterial clearance and alterations in intestinal epithelial and lymphocyte apoptosis may help explain this differential response.
虽然大多数脓毒症患者存在基础合并症,但大多数脓毒症动物模型使用的是感染前健康的小鼠。恶性肿瘤是与脓毒症最常见的合并症。本研究的目的是确定患有癌症的小鼠对脓毒症的反应是否与健康动物不同。
前瞻性、随机对照研究。
大学医学中心的动物实验室。
C57Bl/6 小鼠。
动物接受皮下注射 250,000 个可移植胰腺腺癌细胞系 Pan02 细胞(癌症)或磷酸盐缓冲盐水(健康)。3 周后,给予 Pan02 细胞的小鼠出现可重复的、非转移性肿瘤。两组小鼠随后接受气管内注射铜绿假单胞菌(脓毒症)或 0.9%NaCl(假手术)。术后 24 小时处死动物或进行 7 天的生存随访。
接受假手术的癌症小鼠和健康小鼠表现相似,尽管癌症动物的 T 细胞和 B 细胞凋亡水平较低。与之前接受相同损伤的健康脓毒症小鼠相比,患有癌症的脓毒症小鼠死亡率更高(52%比 28%;p =.04)。这与菌血症增加有关,但局部肺部感染无差异。患有癌症的脓毒症小鼠也有更多的肠道上皮细胞凋亡。尽管脓毒症诱导所有动物的 T 细胞和 B 细胞凋亡增加,但与之前健康的脓毒症小鼠相比,患有癌症的脓毒症小鼠的 T 细胞和 B 细胞凋亡减少。患有癌症的脓毒症小鼠和之前健康的脓毒症小鼠之间的血清和肺细胞因子、肺组织学、全血细胞计数和肠道增殖无差异。
当受到相同的脓毒症刺激时,患有癌症的小鼠的死亡率高于之前健康的动物。全身细菌清除减少和肠道上皮细胞和淋巴细胞凋亡改变可能有助于解释这种不同的反应。